Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China · Delayed Price · Currency is CNY 62.43
+3.25 (5.49%)
At close: Apr 1, 2026
SHE:301033 Revenue
Medprin Regenerative Medical Technologies had revenue of 91.45M CNY in the quarter ending September 30, 2025, with 32.74% growth. This brings the company's revenue in the last twelve months to 336.73M, up 21.99% year-over-year. In the year 2024, Medprin Regenerative Medical Technologies had annual revenue of 278.44M with 20.61% growth.
Revenue (ttm)
336.73M
Revenue Growth
+21.99%
P/S Ratio
12.37
Revenue / Employee
999.20K
Employees
337
Market Cap
4.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 278.44M | 47.57M | 20.61% |
| Dec 31, 2023 | 230.87M | 35.62M | 18.24% |
| Jan 1, 2023 | 195.25M | 41.47M | 26.96% |
| Jan 1, 2022 | 153.79M | 30.27M | 24.51% |
| Dec 31, 2020 | 123.51M | 10.27M | 9.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GKHT Medical Technology | 7.22B |
| Guangdong Biolight Meditech | 1.05B |
| Shanghai Kinetic Medical | 1.02B |
| Zhejiang Orient Gene Biotech | 958.99M |
| Hangzhou AGS MedTech | 597.21M |
| Ningbo David Medical Device | 516.76M |
| Nanjing Medlander Medical Technology | 431.59M |
| Wuhan Easy Diagnosis Biomedicine | 351.25M |